Literature DB >> 33560387

Impact of treatment delay in acute myeloid leukemia revisited.

Gunnar Juliusson1,2,3,4, Oskar Hagberg5, Vladimir Lj Lazarevic1, Sören Lehmann6,7, Martin Höglund6,7.   

Abstract

Entities:  

Year:  2021        PMID： 33560387      PMCID： PMC7876876          DOI： 10.1182/bloodadvances.2020003806

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  7 in total

Review 1.  Acute Myeloid Leukemia.

Authors:  Hartmut Döhner; Daniel J Weisdorf; Clara D Bloomfield
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

2.  Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

Authors:  Christoph Röllig; Michael Kramer; Christoph Schliemann; Jan-Henrik Mikesch; Björn Steffen; Alwin Krämer; Richard Noppeney; Kerstin Schäfer-Eckart; Stefan W Krause; Mathias Hänel; Regina Herbst; Volker Kunzmann; Hermann Einsele; Edgar Jost; Tim H Brümmendorf; Sebastian Scholl; Andreas Hochhaus; Andreas Neubauer; Kristina Sohlbach; Lars Fransecky; Martin Kaufmann; Dirk Niemann; Markus Schaich; Norbert Frickhofen; Alexander Kiani; Frank Heits; Ulrich Krümpelmann; Ulrich Kaiser; Johannes Kullmer; Maxi Wass; Friedrich Stölzel; Malte von Bonin; Jan Moritz Middeke; Christian Thiede; Johannes Schetelig; Wolfgang E Berdel; Gerhard Ehninger; Claudia D Baldus; Carsten Müller-Tidow; Uwe Platzbecker; Hubert Serve; Martin Bornhäuser
Journal:  Blood       Date:  2020-08-13       Impact factor: 22.113

3.  Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period.

Authors:  Gunnar Juliusson; Oskar Hagberg; Vladimir Lj Lazarevic; Emma Ölander; Petar Antunovic; Jörg Cammenga; Lovisa Wennström; Lars Möllgård; Mats Brune; Martin Jädersten; Stefan Deneberg; Sören Lehmann; Åsa Rangert Derolf; Martin Höglund
Journal:  Blood       Date:  2019-10-31       Impact factor: 22.113

4.  Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients.

Authors:  Mikkael A Sekeres; Paul Elson; Matt E Kalaycio; Anjali S Advani; Edward A Copelan; Stefan Faderl; Hagop M Kantarjian; Elihu Estey
Journal:  Blood       Date:  2008-09-30       Impact factor: 22.113

5.  Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia.

Authors:  Sarah Bertoli; Emilie Bérard; Françoise Huguet; Anne Huynh; Suzanne Tavitian; François Vergez; Sophie Dobbelstein; Nicole Dastugue; Véronique Mansat-De Mas; Eric Delabesse; Eliane Duchayne; Cécile Demur; Audrey Sarry; Valérie Lauwers-Cances; Guy Laurent; Michel Attal; Christian Récher
Journal:  Blood       Date:  2013-01-30       Impact factor: 22.113

6.  The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting.

Authors:  Gunnar Juliusson; Martin Jädersten; Stefan Deneberg; Sören Lehmann; Lars Möllgård; Lovisa Wennström; Petar Antunovic; Jörg Cammenga; Fryderyk Lorenz; Emma Ölander; Vladimir Lj Lazarevic; Martin Höglund
Journal:  Blood Adv       Date:  2020-03-24

7.  Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Authors:  Gunnar Juliusson; Petar Antunovic; Asa Derolf; Sören Lehmann; Lars Möllgård; Dick Stockelberg; Ulf Tidefelt; Anders Wahlin; Martin Höglund
Journal:  Blood       Date:  2008-11-13       Impact factor: 22.113
  7 in total
  5 in total

1.  Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting.

Authors:  Fernanda Rodrigues Mendes; Wellington Fernandes da Silva; Raphael da Costa Bandeira de Melo; Douglas Rafaele Almeida Silveira; Elvira Deolinda Rodrigues Pereira Velloso; Vanderson Rocha; Eduardo Magalhaes Rego
Journal:  Ann Hematol       Date:  2021-10-21       Impact factor: 3.673

2.  Time from diagnosis to treatment is associated with survival in patients with acute myeloid leukaemia: An analysis of 55 985 patients from the National Cancer Database.

Authors:  Aseel Alsouqi; Scott D Rothenberger; Michael Boyiadzis; Konstantinos Lontos
Journal:  Br J Haematol       Date:  2022-07-28       Impact factor: 8.615

Review 3.  New Therapeutic Strategies for Adult Acute Myeloid Leukemia.

Authors:  Hiroto Ishii; Shingo Yano
Journal:  Cancers (Basel)       Date:  2022-06-05       Impact factor: 6.575

4.  Real-world challenges in the management of acute myeloid leukemia: a single-center experience from North India.

Authors:  Priyanka Chauhan; Anshul Gupta; M Gopinathan; Akanksha Garg; Smriti Khanna; Ruchi Gupta; Khaliqur Rahman; Dinesh Chandra; Manish Kumar Singh; Soniya Nityanand
Journal:  Ann Hematol       Date:  2022-03-24       Impact factor: 3.673

Review 5.  Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology.

Authors:  Ryan J Stubbins; Annabel Francis; Florian Kuchenbauer; David Sanford
Journal:  Curr Oncol       Date:  2022-08-30       Impact factor: 3.109
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.